SPILLO stands out for its ability to identify target and off-target proteins for any molecule, in development or on the market, on a proteome-wide scale. Its exclusive physics-based technology—experimentally validated—provides key advantages and enhances asset value at every stage of drug R&D.
Products, services, technology
Unbiased analyses of the structural proteome of Homo sapiens and other key organisms to identify targets and off-targets for: - predicting/elucidating therapeutic and/or adverse effects, including rare ones, at the biomolecular level; - identifying opportunities for drug rescue/repurposing; - etc.
- https://www.spillo.ch
- +41 76 626 83 00
- Send an email
- Alessandro Di Domizio
